Injection/Infusion
QUOFENIX POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG
Summary
QUOFENIX POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG — Injection/Infusion containing Delafloxacin (as meglumine). Hong Kong Registration No. HK-68500. Certificate Holder: A. MENARINI HONG KONG LIMITED. Date of Registration: 15 Dec, 2024.
Product NameQUOFENIX POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG
Registration No.HK-68500
Certificate HolderA. MENARINI HONG KONG LIMITED
Holder Address20/F, CROCODILE CENTER, NO. 79, HOI YUEN ROAD, KWUN TONG, KOWLOON
IngredientsDelafloxacin (as meglumine)
Dosage FormInjection/Infusion
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration15 Dec, 2024
ATC codesJ01MA23
ATC Classification
ATC level 1
J Antiinfectives for Systemic Use
All ATC groupsJ01
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。